Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome

Table 5 Risk factors associated with the development of anxiety symptoms in female patients with MDD and comorbid Mets

Variables	Coefficients	Std.error	t	P value	95% confidence interval for EXP (B)
Variables	EXP (B)				Lower	Upper
(constant)	24.278	4.895	4.960	0.000	14.548	34.008
Age (years)	-1.556	0.783	-1.987	0.050	-3.115	0.003
Duration of disease (months)	0.100	0.074	1.347	0.182	-0.048	0.248
Age of onset (years)	1.594	0.787	2.026	0.046	0.028	3.160
HAMD	0.389	0.099	3.949	0.000	0.193	0.586
TSH, µIU/L	0.166	0.114	1.447	0.152	-0.062	0.393
TgAb, IU/L	0.001	0.001	1.656	0.101	0.000	0.002
TPOAb, IU/L	-0.001	0.001	-1.093	0.278	-0.002	0.001

Note:
HAMD = Hamilton depression rating scale; TSH: Thyroid Stimulating Hormone; TgAb: Thyroglobulin antibody; TPO-Ab: Thyroid peroxidase
Bold indicate significant correlations between components

ISSN: 1471-244X